Cargando…
K21 Compound, a Potent Antifungal Agent: Implications for the Treatment of Fluconazole-Resistant HIV-Associated Candida Species
Background/Objectives: With mucocutaneous candidiasis being highly prevalent in HIV patients, the emergence of fluconazole-resistant Candida species forms a major challenge in treating and eradicating these infections. The objective of this study was to establish the antifungal activity of K21, a me...
Autores principales: | John, Cathy N., Abrantes, Pedro M. D. S., Prusty, Bhupesh K., Ablashi, Dharam V., Africa, Charlene W. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558409/ https://www.ncbi.nlm.nih.gov/pubmed/31231313 http://dx.doi.org/10.3389/fmicb.2019.01021 |
Ejemplares similares
-
Candida antifungal drug resistance in sub-Saharan African populations: A systematic review
por: Africa, Charlene Wilma Joyce, et al.
Publicado: (2017) -
Synergistic effects of tacrolimus and azole antifungal compounds in fluconazole-susceptible and fluconazole-resistant Candida glabrata
isolates
por: Denardi, Laura Bedin, et al.
Publicado: (2015) -
Synergistic Antifungal Activity of Chitosan with Fluconazole against Candida albicans, Candida tropicalis, and Fluconazole-Resistant Strains
por: Lo, Wei-Hsuan, et al.
Publicado: (2020) -
Potent Antifungal Activity of Pure Compounds from Traditional Chinese Medicine Extracts against Six Oral Candida Species and the Synergy with Fluconazole against Azole-Resistant Candida albicans
por: Yan, Zhimin, et al.
Publicado: (2012) -
Antifungal activities of tacrolimus in combination with antifungal agents against fluconazole-susceptible and fluconazole-resistant Trichosporon asahii isolates
por: Kubiça, Thaís Felli, et al.
Publicado: (2016)